TW200700072A - Method for treatment of hepatic cancer - Google Patents

Method for treatment of hepatic cancer

Info

Publication number
TW200700072A
TW200700072A TW095107608A TW95107608A TW200700072A TW 200700072 A TW200700072 A TW 200700072A TW 095107608 A TW095107608 A TW 095107608A TW 95107608 A TW95107608 A TW 95107608A TW 200700072 A TW200700072 A TW 200700072A
Authority
TW
Taiwan
Prior art keywords
hepatic cancer
treatment
hepatic
cancer
benzamido
Prior art date
Application number
TW095107608A
Other languages
English (en)
Inventor
Takashi Arima
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of TW200700072A publication Critical patent/TW200700072A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW095107608A 2005-03-08 2006-03-07 Method for treatment of hepatic cancer TW200700072A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65907805P 2005-03-08 2005-03-08

Publications (1)

Publication Number Publication Date
TW200700072A true TW200700072A (en) 2007-01-01

Family

ID=36953298

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095107608A TW200700072A (en) 2005-03-08 2006-03-07 Method for treatment of hepatic cancer

Country Status (10)

Country Link
US (1) US20080275002A1 (zh)
EP (1) EP1862168A4 (zh)
JP (1) JPWO2006095704A1 (zh)
KR (1) KR20070108941A (zh)
CN (1) CN101137386A (zh)
AU (1) AU2006221479B2 (zh)
CA (1) CA2600358A1 (zh)
RU (1) RU2401660C2 (zh)
TW (1) TW200700072A (zh)
WO (1) WO2006095704A1 (zh)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE223713T1 (de) * 1995-04-10 2002-09-15 Taiho Pharmaceutical Co Ltd Inhibitor der krebsmetastasierung
EP1500401A4 (en) * 2002-04-22 2009-12-23 Res Found Itsuu Lab DRUGS FOR THE TREATMENT OF VASCULAR DISEASES

Also Published As

Publication number Publication date
CA2600358A1 (en) 2006-09-14
US20080275002A1 (en) 2008-11-06
KR20070108941A (ko) 2007-11-13
EP1862168A4 (en) 2008-04-30
CN101137386A (zh) 2008-03-05
AU2006221479B2 (en) 2011-04-21
AU2006221479A1 (en) 2006-09-14
RU2401660C2 (ru) 2010-10-20
RU2007137057A (ru) 2009-04-20
WO2006095704A1 (ja) 2006-09-14
EP1862168A1 (en) 2007-12-05
JPWO2006095704A1 (ja) 2008-08-14

Similar Documents

Publication Publication Date Title
MY148108A (en) Medicaments for the treatment or prevention of fibrotic diseases
IL173203A0 (en) Novel cyano thiazolides, methods for the production thereof, and use thereof as a medicament
MY145590A (en) Phenylacetamides and their use as glucokinase modulators
ZA200810113B (en) Method for the treatment and prevention of ocular disorders
SG135192A1 (en) Substituted pyrazoline compounds, their preparation and use as medicaments
MXPA05011208A (es) Uso de ivermectina para el tratamiento de desordenes dermatologicos.
NZ589445A (en) Rasagiline for parkinson's disease modification
TW200637544A (en) Medicaments for the treatment or prevention of fibrotic diseases
WO2008033460A3 (en) Treating pain, diabetes, and lipid metabolism disorders
WO2007002390A3 (en) Compositions and methods for modulation of smn2 splicing
SI1814534T1 (sl) Derivati aminolevulinske kisline za zdravljenjeaken
IS8493A (is) Notkun á rótigótíni við meðhöndlun og forvörn a dópamín taugafrumumissi
MXPA05007857A (es) Moduladores derivados de indol de receptores nucleares de hormonas esteroideas.
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
TW200745043A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
UA83691C2 (ru) Применение замещенных 2-аминотетралинов для упреждающего лечения болезни паркинсона
TW200635595A (en) Medicaments for the treatment of prevention of fibrotic diseases
UA86399C2 (ru) Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза
EP1784173A4 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING METABOLIC BONE DISEASES CONTAINING ALPHA-ARYLMETHOXYACRYLATE DERIVATIVES
MX2021013711A (es) Acido 6-(2,4-diclorofenil)-5-[4-[(3s)-1-(3-fluoropropil)pirrolidin -3-il]oxifenil]-8,9-dihidro-7h-benzo[7]anuleno-2-carboxilico para su uso en pacientes con cancer de mama metastasico o avanzado.
TW200745042A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
WO2007025229A3 (en) Compositions and their uses directed to hsp27
NZ546440A (en) Treatment of inflammatory bowel disease with 2-methylene-19-nor-vitamin D compounds
HK1106246A1 (en) S-tenatoprazole monohydrated sodium salt and the use thereof in therapy s-
SI1596879T1 (sl) Uporaba spojine kahalalida za pripravo zdravila za zdravljenje luskavice